title: Continuous veno-venous hemofiltration in critically ill patients with multiple organ failure.
abstract: 18 critically ill patients, with multiple organ failure (MOF) (from shock either septic, n = 15, or cardiogenic, n = 3), oliguria and increase in BUN and creatinine were treated with pump driven, high flux continuous veno-venous hemofiltration (CVVH). Replacement fluids were administered in predilution mode. All patients were under respiratory support and vasoactive drugs, and received early nutritional support (N input: 0.2-0.3 g/kg/day). Mean duration of treatment was 9.2 days and mean ultrafiltrate production was 21.4 l/day; treatment resulted in a significant reduction of both urea nitrogen and creatinine blood levels (-20 and -40% of initial values respectively) in spite of a very severe catabolism. The total amount of urea nitrogen removed through CVVH ranged from 15 to 73 g/day (mean 33.5), the median value of urea nitrogen clearance was 12.8 ml/min with a median ultrafiltration coefficient of 0.8. The mean duration of hemofilters was 69 hours (38-108); the efficacy of filters remained stable throughout the entire lifespan and changes were made in case of sudden decrease of ultrafiltration (< ml/min). No major complication was observed in over than 4000 hours of treatment. Pump driven, high flux CVVH proved effective in the control of water electrolyte balance and metabolic homeostasis in a group of critically ill, hemodynamically unstable, catabolic patients with MOF and acute renal failure. In no case we had to add intermittent hemodialysis or to use hemodiafiltration. The constant extracorporeal blood flow and the stable efficacy of hemofilters allowed an easy control of the overall effectiveness of this technique.
authors.affiliation: Department of Anesthesiology, Ospedale San Paolo, Milano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Vesconi
authors.forename: A
authors.initials: A
authors.lastname: Sicignano
authors.forename: P
authors.initials: P
authors.lastname: De Pietri
authors.forename: C
authors.initials: C
authors.lastname: Foroni
authors.forename: A
authors.initials: A
authors.lastname: Minuto
authors.forename: V
authors.initials: V
authors.lastname: Bellato
authors.forename: A
authors.initials: A
authors.lastname: Riboni
mesh_terms: D000328:Adult; D000368:Aged; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006440:Hemofiltration; D006801:Humans; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000378:metabolism / Q000628:therapy*; D013997:Time Factors; D014508:Urea / Q000378:metabolism
chemical_list: D014508:Urea; D003404:Creatinine